[go: up one dir, main page]

CN106967132A - Reactive compound and its preparation method and application in Shenzhou City's honey peach - Google Patents

Reactive compound and its preparation method and application in Shenzhou City's honey peach Download PDF

Info

Publication number
CN106967132A
CN106967132A CN201710207665.3A CN201710207665A CN106967132A CN 106967132 A CN106967132 A CN 106967132A CN 201710207665 A CN201710207665 A CN 201710207665A CN 106967132 A CN106967132 A CN 106967132A
Authority
CN
China
Prior art keywords
compound
honey peach
methanol
shenzhou
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710207665.3A
Other languages
Chinese (zh)
Other versions
CN106967132B (en
Inventor
戚建华
王艳惠
向兰
林燕飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yihe Shenzhou Life And Health Research Institute
Original Assignee
Zhejiang University ZJU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University ZJU filed Critical Zhejiang University ZJU
Priority to CN201710207665.3A priority Critical patent/CN106967132B/en
Publication of CN106967132A publication Critical patent/CN106967132A/en
Application granted granted Critical
Publication of CN106967132B publication Critical patent/CN106967132B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • C07H1/08Separation; Purification from natural products
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention provides reactive compound and its preparation method and application in Shenzhou City's honey peach.After Shenzhou City's honey peach fruit is crushed first, it is placed in methanol and extracts, filtering and concentrating, and extract is carried out to isolate and purify two sequiterpene glycoside reactive compounds of acquisition, one of them is novel compound, is named as SZMT01.Two compounds that the present invention is extracted from Shenzhou City's honey peach can significantly extend the replicability life-span of yeast cells, with anti-senescence function.Find that SZMT01 is the expression by adjusting sod gene by the analysis to SZMT01 anti-aging mechanism, improve the oxidation resistance of yeast, so as to reach the purpose in extension yeast cells replicability life-span.Oxidative stress description of test SZMT01 can improve the survival rate of yeast under conditions of hydrogen peroxide presence.The present invention being studied in terms of anti-aging and treatment senile disease for Shenzhou City's honey peach reactive compound, has important practical significance to new drug development.

Description

深州蜜桃中活性化合物及其制备方法和应用Active compounds in Shenzhou Peach and its preparation method and application

技术领域technical field

本发明涉及医药技术领域,尤其涉及深州蜜桃中的两种活性化合物及其制备方法和应用。The invention relates to the technical field of medicines, in particular to two active compounds in Shenzhou honey peach and its preparation method and application.

背景技术Background technique

根据最新统计数据,全世界60岁及以上老龄人口在2014年已经达到了9.01亿,预计到2050年这个数字将会超过20亿。世界已进入老龄化社会,随之而来的与衰老相关的疾病已成为日益显著的问题,包括阿尔茨海默病、帕金森在内的神经退行性疾病是世界性的医学难题之一。仅在中国,阿尔茨海默病的患者数量在2010年已增加至569万。在医药学领域,寻找防治老年性疾病的药物已经成为当务之急。According to the latest statistics, the number of people aged 60 and above in the world reached 901 million in 2014, and this number is expected to exceed 2 billion by 2050. The world has entered an aging society, and the accompanying diseases related to aging have become increasingly significant problems. Neurodegenerative diseases including Alzheimer's disease and Parkinson's disease are one of the worldwide medical problems. In China alone, the number of patients with Alzheimer's disease has increased to 5.69 million in 2010. In the field of medicine, finding medicines for preventing and treating senile diseases has become a top priority.

经过对衰老机制的长期研究,本领域内已形成多种衰老学说,包括程序衰老说、体细胞突变说、错误成灾说,自由基说、神经内分泌说、免疫衰老说等等。由此可见,衰老是一个十分复杂的过程,即便是同一类抗衰老药物,其发挥药效的方式也不尽相同,彼此之间无必然联系。After long-term research on the mechanism of aging, a variety of aging theories have been formed in this field, including the theory of programmed aging, somatic cell mutation, error disaster, free radical theory, neuroendocrine theory, immune aging theory and so on. It can be seen that aging is a very complicated process. Even the same type of anti-aging drugs have different ways of exerting their effects, and there is no necessary connection between them.

深州蜜桃来源于河北省深州市,此地具有独特的地理环境和土壤条件,盛产蜜桃,特色鲜明。深州市也被国家林业局命名为“中国蜜桃之乡”。深州蜜桃个头硕大、果型独特、色泽绚丽、果顶凸尖、缝合线深、皮薄肉细、汁甜如蜜、香味浓郁等独特的风味特色,被誉为桃中之王,又称魁桃。历经两千多年,一直作为皇室贡品,是独有的名贵品种,史称“贡桃”。Shenzhou peaches come from Shenzhou City, Hebei Province. This place has a unique geographical environment and soil conditions. It is rich in peaches and has distinctive characteristics. Shenzhou City was also named "Hometown of Chinese Peach" by the State Forestry Administration. Shenzhou peaches are huge in size, unique in shape, gorgeous in color, protruding at the top of the fruit, deep in suture, thin in skin and thin in flesh, sweet as honey in juice, and rich in fragrance. They are known as the king of peaches, also known as Kui Tao. After more than two thousand years, it has been used as a tribute to the royal family. It is a unique and precious variety, known as "tribute peach" in history.

发明内容Contents of the invention

本发明的目的是提供一种深州蜜桃中的活性化合物1(化合物SZMT01)和化合物2,所述的深州蜜桃中的活性化合物为倍半萜苷类化合物,其中化合物1为倍半萜酯苷类新结构化合物,两种活性化合物具有较强的抗衰老能力。其结构式如下:The object of the present invention is to provide a kind of active compound 1 (compound SZMT01) and compound 2 in Shenzhou honey peach, the active compound in described Shenzhou honey peach is sesquiterpene glycoside compound, and wherein compound 1 is sesquiterpene A new structure compound of terpene glycosides, two active compounds have strong anti-aging ability. Its structural formula is as follows:

上述深州蜜桃活性化合物1的理化性质为:无色粉末;(c 0.16,MeOH);分子式为C21H34O8;高分辨率质谱ESI-TOF-MS m/z 437.2151[M+Na]+,理论值::C21H34O8Na+437.2151;1H和13C NMR如表1所示。The physical and chemical properties of the above Shenzhou peach active compound 1 are: colorless powder; (c 0.16, MeOH); molecular formula is C 21 H 34 O 8 ; high resolution mass spectrum ESI-TOF-MS m/z 437.2151[M+Na] + , theoretical value: C 21 H 34 O 8 Na + 437.2151; 1 H and 13 C NMR are shown in Table 1.

活性化合物2的理化性质为:无色粉末;(c 0.2,MeOH);分子式为C21H36O7;高分辨率质谱ESI-TOF-MS m/z 423.2368[M+Na]+,理论值:C21H36O7Na+423.2359;13CNMR(125MHz,CD3CD)数据如下:δC 14.1(C-13),16.0(C-14),23.7(C-8),27.4(C-4),27.6(C-15),40.3(C-5),43.4(C-9),62.8(C-6′),71.8(C-4′),73.9(C-10),75.1(C-2′),76.0(C-1),77.9(C-5′),78.2(C-3′),102.6(C-1′),112.0(C-12),126.0(C-7),129.9(C-3),132.9(C-2),135.7(C-6),146.4(C-11)。The physical and chemical properties of active compound 2 are: colorless powder; (c 0.2, MeOH); molecular formula is C 21 H 36 O 7 ; high resolution mass spectrum ESI-TOF-MS m/z 423.2368[M+Na] + , theoretical value: C 21 H 36 O 7 Na + 423.2359; 13 CNMR (125MHz, CD 3 CD) data are as follows: δ C 14.1(C-13), 16.0(C-14), 23.7(C-8), 27.4(C-4), 27.6(C-15), 40.3( C-5), 43.4(C-9), 62.8(C-6′), 71.8(C-4′), 73.9(C-10), 75.1(C-2′), 76.0(C-1), 77.9 (C-5′), 78.2 (C-3′), 102.6 (C-1′), 112.0 (C-12), 126.0 (C-7), 129.9 (C-3), 132.9 (C-2 ), 135.7 (C-6), 146.4 (C-11).

本发明的另一个目的是提供深州蜜桃中两个活性化合物1(化合物SZMT01)和化合物2的制备方法,通过以下步骤实现:Another object of the present invention is to provide the preparation method of two active compounds 1 (compound SZMT01) and compound 2 in Shenzhou honey peach, realize through the following steps:

(1)取深州蜜桃果实,粉碎后,置于甲醇中浸提,过滤浓缩,获得浸提物;(1) Take the Shenzhou peach fruit, crush it, place it in methanol for extraction, filter and concentrate to obtain the extract;

(2)对浸提物进行分离纯化,获得所述深州蜜桃活性化合物1和化合物2。(2) Separating and purifying the extract to obtain the Shenzhou peach active compound 1 and compound 2.

作为优选,步骤(1)中,所述浸提的温度为25~30℃,时间为0.5~24h。更优选,所述浸提的温度为25℃室温,时间为24h。Preferably, in step (1), the temperature of the leaching is 25-30° C., and the time is 0.5-24 h. More preferably, the temperature of the leaching is 25° C. at room temperature, and the time is 24 hours.

进一步地,步骤(2)中,所述分离纯化的过程包括:Further, in step (2), the process of said separation and purification includes:

(a)以甲醇:水溶剂系统作洗脱剂,对浸提物进行第一次分离,获得目标馏分I;(a) using methanol: water solvent system as eluent, the extract is separated for the first time to obtain target fraction I;

(b)以甲醇:水溶剂系统作洗脱剂,对所述目标馏分I进行第二次分离,获得活性馏分II和活性馏分III;(b) using methanol: water solvent system as eluent, the target fraction I is separated for the second time to obtain active fraction II and active fraction III;

(c)以甲醇水溶液为流动相,利用反相HPLC对活性馏分II和活性馏分III进行第三次分离,获得所述深州蜜桃活性化合物1和化合物2;(c) Using methanol aqueous solution as mobile phase, utilize reversed-phase HPLC to separate active fraction II and active fraction III for the third time to obtain the Shenzhou peach active compound 1 and compound 2;

其中:步骤(a)中,采用十八烷基键合硅胶开口柱进行分离;甲醇:水溶剂系统按体积比30:70,50:50,70:30,100:0依次洗脱,体积比70:30洗脱的馏分为目标馏分I。Wherein: in step (a), an octadecyl bonded silica gel open column is used for separation; methanol: water solvent system is eluted sequentially at a volume ratio of 30:70, 50:50, 70:30, and 100:0, and the volume ratio is 70: The 30 eluted fraction is the target fraction I.

步骤(b)中,采用十八烷基键合硅胶开口柱进行分离;甲醇:水溶剂系统按照体积比50:50,55:45,60:40,65:35,70:30,80:20,100:0依次洗脱,体积比60:40和65:35洗脱的馏分为活性馏分II和活性馏分III。In step (b), use octadecyl bonded silica gel open column for separation; methanol: water solvent system according to the volume ratio of 50:50,55:45,60:40,65:35,70:30,80:20,100 :0 eluted in turn, the volume ratio 60:40 and 65:35 eluted fractions were active fraction II and active fraction III.

步骤(c)中,所述流动相为63%甲醇水溶液;分离过程中,取保留时间为13.9分钟的馏分,得到深州蜜桃活性化合物1。In step (c), the mobile phase is 63% methanol aqueous solution; during the separation process, the fraction with a retention time of 13.9 minutes is taken to obtain Shenzhou Peach active compound 1.

步骤(c)中,所述流动相为65%甲醇水溶液;分离过程中,取保留时间为14.5分钟的馏分,得到深州蜜桃活性化合物2。In the step (c), the mobile phase is 65% methanol aqueous solution; during the separation process, the fraction with a retention time of 14.5 minutes is taken to obtain Shenzhou Peach active compound 2.

本发明的再一个目的是提供所述深州蜜桃活性化合物在制备抗衰老药物或保健品中的应用,例如将深州蜜桃制成抗衰老蜜桃饮品等。由深州蜜桃活性化合物和药学上可接受的载体制成。研究表明,化合物SZMT01和化合物2在抗衰老化合物的体外筛选模型中,均可以显著延长酵母细胞的复制性寿命。Another object of the present invention is to provide the application of the active compound of Shenzhou peach in the preparation of anti-aging medicine or health products, for example, making Shenzhou peach into an anti-aging peach drink. Made from deep state peach active compounds and pharmaceutically acceptable carriers. Studies have shown that both compound SZMT01 and compound 2 can significantly prolong the replicative lifespan of yeast cells in the in vitro screening model of anti-aging compounds.

所述药学上可接受的载体是指药学领域常规的药物载体,如填充剂、粘合剂、湿润剂、吸收促进剂、表面活性剂等。The pharmaceutically acceptable carrier refers to conventional drug carriers in the pharmaceutical field, such as fillers, adhesives, wetting agents, absorption promoters, surfactants and the like.

所述填充剂可采用淀粉、蔗糖或微晶纤维素;所述粘合剂可采用淀粉浆、羟丙纤维素、明胶或聚乙二醇;所述湿润剂可采用硬脂酸镁、微粉硅胶或聚乙二醇类;所述吸收促进剂可采用聚山梨脂或卵磷脂;所述表面活性剂可采用伯洛沙姆、脂肪酸山梨坦或聚山梨脂。另外还可以加入其它辅剂如香味剂、甜味剂等。The filler can adopt starch, sucrose or microcrystalline cellulose; the binder can adopt starch slurry, hydroxypropyl cellulose, gelatin or polyethylene glycol; the wetting agent can adopt magnesium stearate, micropowder silica gel Or polyethylene glycols; the absorption enhancer can use polysorbate or lecithin; the surfactant can use boloxamer, fatty acid sorbitan or polysorbate. In addition, other adjuvants such as flavoring agents and sweetening agents can also be added.

所述抗衰老药物或保健品的剂型可以是片剂,丸剂,粉剂,分散片,小药囊剂,酏剂,混悬剂,乳剂,溶液剂,糖浆剂,气雾剂,软胶囊,硬胶囊,无菌注射液,搽剂或栓剂;可制成常规、速释、缓释或延迟释放制剂。The dosage form of described anti-aging medicine or health product can be tablet, pill, powder, dispersible tablet, sachet, elixir, suspension, emulsion, solution, syrup, aerosol, soft capsule, hard capsule Capsules, sterile injectable solutions, liniments or suppositories; available in conventional, immediate-release, sustained-release or delayed-release formulations.

本发明的抗衰老药物可通过各种途径给予,包括口服、鼻腔、肌肉注射、皮下注射、静脉注射等。The anti-aging medicine of the present invention can be administered through various routes, including oral administration, nasal cavity injection, intramuscular injection, subcutaneous injection, intravenous injection and the like.

为了进一步探究化合物SZMT01在抗衰老方面的作用机理,我们通过氧化应激实验对化合物SZMT01进行了抗衰老机理初步研究,发现该化合物SZMT01在双氧水存在的条件下可以提高酵母的生存率,同时也发现该化合物是通过调节SOD基因的表达,提高酵母的抗氧化能力,从而实现酵母细胞复制性寿命的延长的。In order to further explore the anti-aging mechanism of compound SZMT01, we conducted a preliminary study on the anti-aging mechanism of compound SZMT01 through oxidative stress experiments, and found that the compound SZMT01 can improve the survival rate of yeast in the presence of hydrogen peroxide, and also found that The compound improves the antioxidant capacity of yeast by regulating the expression of SOD gene, thereby prolonging the replicative lifespan of yeast cells.

根据氧化自由基学说,氧化压力是导致衰老的主要原因。即使在正常条件下线粒体也会产生有害的代谢产物—活性氧(ROS),这些物质会破坏细胞膜和生物大分子,例如蛋白和核酸,进而破坏细胞的功能,引起衰老和死亡。According to the oxidative free radical theory, oxidative stress is the main cause of aging. Even under normal conditions, mitochondria can produce harmful metabolites—reactive oxygen species (ROS), which can damage cell membranes and biomacromolecules, such as proteins and nucleic acids, thereby disrupting cell functions, causing aging and death.

SOD是一个与抗氧化应激相关的基因。化合物SZMT01不能延长SOD敲除后的酵母的复制性寿命,进而证明SZMT01是通过调节SOD基因的表达,从而实现酵母细胞复制性寿命的延长的。SOD is a gene associated with resistance to oxidative stress. The compound SZMT01 could not prolong the replicative lifespan of the SOD-knockout yeast, which further proves that SZMT01 prolongs the replicative lifespan of yeast cells by regulating the expression of the SOD gene.

与现有技术相比,本发明具有以下有益效果:Compared with the prior art, the present invention has the following beneficial effects:

(1)在酵母衰老模型K6001酿酒酵母细胞中,本发明从深州蜜桃中提取出的化合物SZMT01和2能够显著延长酵母细胞的复制性寿命,具有很强的抗衰老能力。(1) In the yeast aging model K6001 Saccharomyces cerevisiae cells, the compounds SZMT01 and 2 extracted from Shenzhou peach in the present invention can significantly prolong the replicative lifespan of yeast cells and have strong anti-aging ability.

(2)本发明深州蜜桃活性化合物对延缓衰老及治疗衰老性疾病方面的新药研发进行基础性研究,具有重要的现实意义。(2) The Shenzhou Peach active compound of the present invention has important practical significance for basic research on the research and development of new drugs for delaying aging and treating senile diseases.

附图说明Description of drawings

图1为实施例2中制备获得的深州蜜桃活性化合物1(A)和化合物2(B)对酵母K6001复制性寿命的影响结果;其中,Control表示阴性对照;Res(Resveratrol)为阳性对照白藜芦醇(10μM);1 7.5μM表示浓度为7.5μM的化合物1,1 25μM表示浓度为25μM的化合物1;27.5μM表示浓度为7.5μM的化合物2,2 25μM表示浓度为25μM的化合物2。Fig. 1 is the effect result of Shenzhou peach active compound 1 (A) and compound 2 (B) obtained in embodiment 2 on yeast K6001 replicative lifespan; Wherein, Control represents negative control; Res (Resveratrol) is positive control Resveratrol (10 μM); 1 7.5 μM indicates compound 1 at a concentration of 7.5 μM, 1 25 μM indicates compound 1 at a concentration of 25 μM; 27.5 μM indicates compound 2 at a concentration of 7.5 μM, 2 25 μM indicates compound 2 at a concentration of 25 μM .

图2为实施例3中活性化合物1对酵母突变菌株Δsod1(A)和Δsod2(B)复制性寿命的影响结果;其中,Control(K6001)表示未添加活性化合物1的K6001酵母;Control(Δsod1)和Control(Δsod2)分别表示未添加活性化合物1的K6001酵母突变菌株Δsod1和Δsod2;1 7.5μM(Δsod1)和1 7.5μM(Δsod2)分别表示添加7.5μM活性化合物1的K6001酵母突变菌株Δsod1和Δsod2。Fig. 2 is the result of the effect of active compound 1 on the replicative lifespan of yeast mutant strains Δsod1 (A) and Δsod2 (B) in Example 3; wherein, Control (K6001) represents the K6001 yeast without adding active compound 1; Control (Δsod1) and Control(Δsod2) respectively represent K6001 yeast mutant strains Δsod1 and Δsod2 without adding active compound 1; .

图3为实施例3中活性化合物1氧化应激实验结果;其中,Control(K6001)表示未添加活性化合物1的K6001酵母;Control表示阴性对照;Res(Resveratrol)为阳性对照白藜芦醇(10μM);1 7.5μM表示浓度为7.5μM的化合物1,1 25μM表示浓度为25μM的化合物1。Fig. 3 is the oxidative stress test result of active compound 1 in embodiment 3; Wherein, Control (K6001) represents the K6001 yeast that does not add active compound 1; Control represents negative control; Res (Resveratrol) is positive control resveratrol (10 μ M ); 1 7.5 μM indicates compound 1 at a concentration of 7.5 μM, and 1 25 μM indicates compound 1 at a concentration of 25 μM.

具体实施方式detailed description

本发明结合附图和实施例做进一步的说明。The present invention is further described in conjunction with drawings and embodiments.

实施例1Example 1

1、深州蜜桃中活性化合物1和化合物2的制备,具体步骤如下:1. The preparation of active compound 1 and compound 2 in Shenzhou honey peach, the specific steps are as follows:

(1)将3.0kg深州蜜桃置于甲醇(工业级)中,室温下浸提24小时(震荡);经抽滤浓缩后,得到甲醇浸提物100.0g。(1) Put 3.0 kg of Shenzhou peaches in methanol (industrial grade) and extract at room temperature for 24 hours (shaking); after concentrated by suction filtration, 100.0 g of methanol extracts were obtained.

(2)将甲醇浸提物用十八烷基键合硅胶开口柱进行分离,以甲醇:水溶剂系统作洗脱剂,按甲醇:水的体积比=30:70,50:50,70:30,100:0,依次洗脱,取体积比70:30洗脱的馏分0.7g。(2) Separating the methanol extract with an octadecyl bonded silica gel open column, using methanol:water solvent system as eluent, according to the volume ratio of methanol:water=30:70,50:50,70: 30,100:0, eluted in sequence, and 0.7g of the fraction eluted with a volume ratio of 70:30 was taken.

(3)将步骤(2)所取馏分用十八烷基键合硅胶开口柱进行纯化,以甲醇∶水溶剂系统作洗脱剂,按甲醇∶水的体积比=50:50,55:45,60:40,65:35,70:30,80:20,100:0依次洗脱,取体积比60:40和65:35分别洗脱的馏分3.7mg和2.3mg。(3) Purify the fraction obtained in step (2) with an open column of octadecyl bonded silica gel, using methanol: water solvent system as eluent, according to the volume ratio of methanol: water = 50:50, 55:45 , 60:40, 65:35, 70:30, 80:20, and 100:0 were eluted in sequence, and 3.7 mg and 2.3 mg of fractions eluted at volume ratios of 60:40 and 65:35 were taken.

(4)取步骤(3)所取馏分,用反向HPLC纯化,色谱条件:色谱柱ODS-HG-5(10/250mm),流速3ml/min,检测波长210nm,流动相为63%甲醇水溶液,得到活性化合物1 1.1mg(保留时间为13.9min);流动相为65%甲醇水溶液,得到活性化合物2 1.8mg(保留时间为14.5min)。2、活性化合物1和化合物2的理化特征及化学结构分析(4) Get the cut that step (3) takes, purify with reverse HPLC, chromatographic condition: chromatographic column ODS-HG-5 (10/250mm), flow rate 3ml/min, detection wavelength 210nm, mobile phase is 63% aqueous methanol , to obtain 1.1 mg of active compound 1 (retention time of 13.9 min); the mobile phase was 65% aqueous methanol, and 1.8 mg of active compound 2 was obtained (retention time of 14.5 min). 2. Physical and chemical characteristics and chemical structure analysis of active compound 1 and compound 2

13C NMR、1H NMR、HRMS、HSQC、HMBC、NOESY分析,结果如下:After 13 C NMR, 1 H NMR, HRMS, HSQC, HMBC, NOESY analysis, the results are as follows:

化合物1的理化性质:无色粉末,分子式为C21H34O8,高分辨率质谱ESI-TOF-MS m/z437.2151[M+Na]+1H NMR和13C NMR的数据见下表1。Physical and chemical properties of compound 1: colorless powder, molecular formula C 21 H 34 O 8 , high-resolution mass spectrum ESI-TOF-MS m/z 437.2151[M+Na] + . 1 H NMR and 13 C NMR data are shown in Table 1 below.

表1 11H NMR和13C NMR数据(CD3OD;δ/ppm,J/Hz).Table 1 1 1 H NMR and 13 C NMR data (CD 3 OD; δ/ppm, J/Hz).

a500MHz,b125MHz a 500MHz, b 125MHz

化合物2的理化性质:无色粉末,分子式为C21H36O7;高分辨率质谱ESI-TOF-MS m/z423.2368[M+Na]+13C NMR(125MHz,CD3CD)数据如下:δC 14.1(C-13),16.0(C-14),23.7(C-8),27.4(C-4),27.6(C-15),40.3(C-5),43.4(C-9),62.8(C-6′),71.8(C-4′),73.9(C-10),75.1(C-2′),76.0(C-1),77.9(C-5′),78.2(C-3′),102.6(C-1′),112.0(C-12),126.0(C-7),129.9(C-3),132.9(C-2),135.7(C-6),146.4(C-11)。Physicochemical properties of compound 2: colorless powder, molecular formula C 21 H 36 O 7 ; high-resolution mass spectrum ESI-TOF-MS m/z 423.2368[M+Na] + . 13 C NMR (125MHz, CD 3 CD) data are as follows: δC 14.1( C -13), 16.0(C-14), 23.7(C-8), 27.4(C-4), 27.6(C-15), 40.3 (C-5), 43.4 (C-9), 62.8 (C-6′), 71.8 (C-4′), 73.9 (C-10), 75.1 (C-2′), 76.0 (C-1 ), 77.9 (C-5′), 78.2 (C-3′), 102.6 (C-1′), 112.0 (C-12), 126.0 (C-7), 129.9 (C-3), 132.9 (C -2), 135.7(C-6), 146.4(C-11).

化合物1和化合物2的结构式如下;The structural formulas of compound 1 and compound 2 are as follows;

实施例2深州蜜桃中活性化合物1(SZMT01)和化合物2的抗衰老活性分析Anti-aging activity analysis of active compound 1 (SZMT01) and compound 2 in Shenzhou honey peach in embodiment 2

目前,用于抗衰老研究的生物模型主要有老鼠,线虫,果蝇和酵母。本实施例选择酿酒酵母作为抗衰老研究的活性系统;因为酵母是单细胞的真核生物,生命周期短,已获其完整的基因组数据,是目前常用的衰老模型生物。At present, the biological models used for anti-aging research mainly include mice, nematodes, fruit flies and yeast. In this example, Saccharomyces cerevisiae was selected as the active system for anti-aging research; because yeast is a single-celled eukaryote with a short life cycle, its complete genome data has been obtained, and it is currently a commonly used aging model organism.

与此同时,以白藜芦醇作为阳性对照,白藜芦醇是目前众所周知的、在多种动物模型上显示抗衰老作用的小分子化合物。At the same time, resveratrol is used as a positive control, which is a well-known small molecular compound that shows anti-aging effects in various animal models.

分析方法的步骤如下:The steps of the analysis method are as follows:

(1)从-30℃冰箱取出K6001酵母菌株,用PBS洗涤三次,每次5ml,除去其中的甘油;再加入1ml PBS,吹打,使其悬浮后加入到5ml液体培养基(1%的酵母粉,2%的蛋白胨,3%的半乳糖)中;28℃振摇(160r/min)培养24小时。(1) Take out the K6001 yeast strain from the refrigerator at -30°C, wash it three times with PBS, 5ml each time, and remove the glycerol therein; then add 1ml PBS, pipette to suspend it, and then add it to 5ml liquid medium (1% yeast powder , 2% peptone, 3% galactose); cultured at 28° C. for 24 hours with shaking (160 r/min).

(2)培养结束后,用5ml PBS洗涤三次,除去其中的液体培养基,用血球计数板计数,计算酵母的浓度。(2) After the cultivation, wash three times with 5ml PBS, remove the liquid medium therein, count with a hemocytometer, and calculate the concentration of yeast.

(3)采用无水乙醇作溶剂,配制7.5μM,25μM的1和2,10μM的白藜芦醇,备用。(3) Using absolute ethanol as a solvent, prepare 7.5 μM, 25 μM 1 and 2, and 10 μM resveratrol for later use.

(4)在灭菌的培养皿中加入5ml的固体培养基(1%的酵母粉,2%的蛋白胨,2%的葡萄糖,2%的琼脂粉),待培养基凝固后,向其中分别加入步骤(3)中配制好的样品,溶剂挥发后加入4000个酵母,用涂布器涂抹均匀,28℃恒温培养48小时。(4) Add 5ml of solid medium (1% yeast powder, 2% peptone, 2% glucose, 2% agar powder) to the sterilized petri dish. After the medium solidifies, add For the sample prepared in step (3), 4,000 yeasts were added after the solvent evaporated, spread evenly with a spreader, and incubated at a constant temperature of 28°C for 48 hours.

(5)显微镜下每皿随机数出40个母细胞分别产生的子细胞个数,并记录、作图分析,结果见图1。(5) Randomly count the number of daughter cells produced by 40 mother cells in each plate under the microscope, record, draw and analyze. The results are shown in Figure 1.

由图1可知,阴性对照(未添加样品,Control)的平均寿命为7.10±0.34,阳性对照(添加10μM的白藜芦醇,Resverstrol)是8.40±0.47*;7.5μM,25μM浓度的1分别是8.87±0.53**,8.37±0.51*;7.5μM,25μM浓度的2分别是8.40±0.54*,8.20±0.41*。(*p<0.05,**p<0.01).As can be seen from Figure 1, the average lifespan of the negative control (no sample added, Control) is 7.10 ± 0.34, and that of the positive control (10 μM resveratrol, Resverstrol) is 8.40 ± 0.47*; 7.5 μM and 25 μM concentrations of 1 are 8.87±0.53**, 8.37±0.51*; 7.5μM, 25μM concentrations of 2 were 8.40±0.54*, 8.20±0.41*, respectively. (*p<0.05,**p<0.01).

因此,化合物1和化合物2能延长酵母的复制性寿命。Therefore, Compound 1 and Compound 2 can prolong the replicative lifespan of yeast.

实施例3深州蜜桃中活性化合物1抗衰老机制分析Example 3 Anti-aging Mechanism Analysis of Active Compound 1 in Shenzhou Peach

1、测试1在7.5μM的活性浓度下是否能够延长敲除了SOD基因的K6001酵母突变菌株Δsod1和Δsod2的复制性寿命。1. To test whether 1 can prolong the replicative lifespan of K6001 yeast mutant strains Δsod1 and Δsod2 with the SOD gene knocked out at an active concentration of 7.5 μM.

分析方法的步骤如下:The steps of the analysis method are as follows:

(1)从-30℃冰箱取出K6001酵母菌株和K6001酵母突变菌株Δsod1和Δsod2,用PBS洗涤三次,每次5ml,除去其中的甘油;再加入1ml PBS,吹打,使其悬浮后加入到5ml液体培养基(1%的酵母粉,2%的蛋白胨,3%的半乳糖)中;28℃振摇(160r/min)培养24小时。(1) Take out the K6001 yeast strain and the K6001 yeast mutant strains Δsod1 and Δsod2 from the -30°C refrigerator, wash with PBS three times, 5ml each time, and remove the glycerol; then add 1ml of PBS, pipette to suspend, and then add to 5ml of liquid culture medium (1% yeast powder, 2% peptone, 3% galactose); cultured at 28° C. with shaking (160 r/min) for 24 hours.

(2)培养结束后,用5ml PBS洗涤三次,除去其中的液体培养基,用血球计数板计数,计算酵母的浓度。(2) After the cultivation, wash three times with 5ml PBS, remove the liquid medium therein, count with a hemocytometer, and calculate the concentration of yeast.

(3)采用无水乙醇作溶剂,配制7.5μM的1,备用。(3) Using absolute ethanol as a solvent, prepare 7.5 μM of 1 and set aside.

(4)在灭菌的培养皿中加入5ml的固体培养基(1%的酵母粉,2%的蛋白胨,2%的葡萄糖,2%的琼脂粉),待培养基凝固后,向其中分别加入步骤(3)中配制好的样品,溶剂挥发后。加入4000个酵母(K6001酵母菌株或者K6001酵母突变菌株Δsod1和Δsod2,用涂布器涂抹均匀,28℃恒温培养48小时。(4) Add 5ml of solid medium (1% yeast powder, 2% peptone, 2% glucose, 2% agar powder) to the sterilized petri dish. After the medium solidifies, add The sample prepared in step (3), after the solvent evaporates. Add 4000 yeasts (K6001 yeast strain or K6001 yeast mutant strains Δsod1 and Δsod2, spread evenly with a spreader, and incubate at a constant temperature of 28°C for 48 hours.

(5)显微镜下每皿随机数出40个母细胞分别产生的子细胞个数,并记录、作图分析,结果见图2。(5) Randomly count the number of daughter cells produced by 40 mother cells in each plate under the microscope, record, draw and analyze. The results are shown in Figure 2.

由图2可知,K6001菌株上阴性对照(未添加样品,Control)的平均寿命为6.85±0.42,阳性对照(添加10μM的白藜芦醇,Resverstrol)是8.70±0.48**,7.5μM浓度的1是8.40±0.48*;K6001酵母突变菌株Δsod1上阴性对照(未添加样品,Control)的平均寿命为6.55±0.33,阳性对照(添加10μM的白藜芦醇,Resverstrol)是6.95±0.32,7.5μM浓度的1是7.05±0.37;K6001酵母突变菌株Δsod2上阴性对照(未添加样品,Control)的平均寿命为6.65±0.36,阳性对照(添加10μM的白藜芦醇,Resverstrol)是7.17±0.46,7.5μM浓度的1是7.25±0.32。(*p<0.05,**p<0.01)It can be seen from Figure 2 that the average lifespan of the negative control (no sample added, Control) on the K6001 strain was 6.85±0.42, and the positive control (10 μM resveratrol, Resverstrol) was 8.70±0.48**, 7.5 μM concentration of 1 is 8.40±0.48*; the average lifespan of the negative control (no sample added, Control) on the K6001 yeast mutant strain Δsod1 is 6.55±0.33, and the positive control (10 μM resveratrol, Resverstrol) is 6.95±0.32, 7.5 μM concentration 1 is 7.05±0.37; the average lifespan of the negative control (no sample added, Control) on the K6001 yeast mutant strain Δsod2 is 6.65±0.36, and the positive control (10 μM resveratrol, Resverstrol) is 7.17±0.46, 7.5 μM The concentration of 1 is 7.25 ± 0.32. (*p<0.05,**p<0.01)

因此,化合物1在7.5μM的活性浓度下不能够延长敲除了SOD基因的K6001酵母突变菌株Δsod1和Δsod2的复制性寿命。Therefore, Compound 1 was unable to prolong the replicative lifespan of K6001 yeast mutant strains Δsod1 and Δsod2 in which the SOD gene was knocked out at an active concentration of 7.5 μM.

实施例5SZMT01提高酵母生存率的活性分析Embodiment 5 SZMT01 improves the activity analysis of yeast viability

测试SZMT01能否提高酵母的生存率,测试方法如下:To test whether SZMT01 can improve the survival rate of yeast, the test method is as follows:

(1)将-30℃保存的野生型酵母BY4741用5ml PBS洗涤三次,除去其中的甘油;加入1ml无菌水,吹打使其悬浮,加入到5ml葡萄糖培养基(1%的酵母粉,2%的蛋白胨,2%的葡萄糖)中;将其放入摇床,28℃振摇(160r/min)培养24小时,使其恢复生长能力。(1) Wash the wild-type yeast BY4741 stored at -30°C with 5ml PBS three times to remove the glycerol; add 1ml sterile water, blow it to suspend it, add it to 5ml glucose medium (1% yeast powder, 2% peptone, 2% glucose); put it into a shaker, and shake (160r/min) at 28°C for 24 hours to restore its growth ability.

(2)将BY4741接种到25mL新的葡萄糖培养基,调整OD600值为0.1,然后分别与7.5μM、25μM的胆固醇和阳性对照品(10μM的白藜芦醇,Resverstrol)孵育12小时。(2) Inoculate BY4741 into 25 mL of new glucose medium, adjust the OD 600 value to 0.1, and then incubate with 7.5 μM, 25 μM cholesterol and positive control substance (10 μM resveratrol, Resverstrol) for 12 hours.

(3)取各组含有相同酵母细胞的培养液5μL滴在含有9mM H2O2的葡萄糖固体培养基(1%的酵母粉,2%的蛋白胨,2%的葡萄糖,2%琼脂)上;28℃培养3天后观察酵母的生长状况并照相,观察结果见图3。(3) 5 μL of culture solution containing the same yeast cells in each group was dropped on glucose solid medium (1% yeast powder, 2% peptone, 2% glucose, 2% agar) containing 9mM H 2 O 2 ; After culturing at 28°C for 3 days, the growth status of the yeast was observed and photographed, and the observation results are shown in Figure 3.

由图3可见,与阴性对照相比,在含有9mM H2O2的葡萄糖固体培养基上,7.5μM、25μM的SZMT01明显提高了酵母的生存率。It can be seen from Figure 3 that compared with the negative control, 7.5 μM and 25 μM SZMT01 significantly increased the survival rate of yeast on the glucose solid medium containing 9mM H 2 O 2 .

Claims (10)

1. reactive compound in a kind of Shenzhou City's honey peach, it is characterised in that Shenzhou City's honey peach reactive compound is referred to as compound 1, Its structural formula is:
2. the preparation method of reactive compound in a kind of Shenzhou City's honey peach, it is characterised in that the compound is respectively the He of compound 1 Compound 2, is realized by following steps:
(1) Shenzhou City's honey peach fruit is taken, after crushing, is placed in methanol and shakes extraction, filtering and concentrating obtains extract;
(2) extract is isolated and purified, obtains described Shenzhou City's honey peach reactive compound;
The structural formula of compound 1 and compound 2 is as follows:
3. preparation method according to claim 2, it is characterised in that in step (1), the temperature of the extraction is room temperature, Time is 24h.
4. preparation method according to claim 2, it is characterised in that described to isolate and purify by following step in step (2) It is rapid to realize:
(a) with methanol:Aqueous solvent system makees eluant, eluent, and first time separation is carried out to extract, obtains target fraction I;
(b) with methanol:Aqueous solvent system makees eluant, eluent, and carrying out second to the target fraction I separates, and obtains active fractions II And III;
(c) using methanol aqueous solution as mobile phase, third time separation is carried out to active fractions II and III using reversed-phase HPLC, respectively Obtain Shenzhou City's honey peach reactive compound 1 and compound 2.
5. preparation method according to claim 4, it is characterised in that in step (a), methanol:Aqueous solvent system presses volume Than 30:70,50:50,70:30,100:0 elutes successively, volume ratio 70:The cut of 30 elutions is target fraction I.
6. preparation method according to claim 4, it is characterised in that in step (b), methanol:Aqueous solvent system is according to body Product compares 50:50,55:45,60:40,65:35,70:30,80:20,100:0 elutes successively, volume ratio 60:40 and 65:35 elutions Cut be active fractions II and active fractions III.
7. preparation method according to claim 4, it is characterised in that in step (c), the mobile phase is 63% methanol-water Solution;In separation process, the cut for taking retention time to be 13.9 minutes obtains Shenzhou City's honey peach reactive compound 1.
8. preparation method according to claim 4, it is characterised in that in step (c), the mobile phase is 65% methanol-water Solution;In separation process, the cut for taking retention time to be 14.5 minutes obtains Shenzhou City's honey peach reactive compound 2.
9. Shenzhou City's honey peach reactive compound that method is prepared according to claim 2 is preparing antiaging agent or health care Application in product, the compound is compound 1 and compound 2.
10. application according to claim 9, it is characterised in that the medicine or health products are as the depth described in claim 1 Two reactive compounds of state honey peach and pharmaceutically acceptable carrier are made.
CN201710207665.3A 2017-03-31 2017-03-31 Reactive compound and its preparation method and application in Shenzhou City's honey peach Active CN106967132B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710207665.3A CN106967132B (en) 2017-03-31 2017-03-31 Reactive compound and its preparation method and application in Shenzhou City's honey peach

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710207665.3A CN106967132B (en) 2017-03-31 2017-03-31 Reactive compound and its preparation method and application in Shenzhou City's honey peach

Publications (2)

Publication Number Publication Date
CN106967132A true CN106967132A (en) 2017-07-21
CN106967132B CN106967132B (en) 2019-05-21

Family

ID=59336439

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710207665.3A Active CN106967132B (en) 2017-03-31 2017-03-31 Reactive compound and its preparation method and application in Shenzhou City's honey peach

Country Status (1)

Country Link
CN (1) CN106967132B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113088394A (en) * 2021-04-26 2021-07-09 江苏省农业科学院 Zhongzhou honey peach essence

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MACAHIG, RENE ANGELO等: "Glucosylated sesquiterpene alcohols from Fraxinus Glucosylated sesquiterpene alcohols from Fraxinus", 《NATURAL PRODUCT COMMUNICATIONS》 *
XI, FENG-MIN等: "Thiophenes, polyacetylenes and terpenes from the aerial parts of Eclipta prostrata", 《BIOORGANIC & MEDICINAL CHEMISTRY》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113088394A (en) * 2021-04-26 2021-07-09 江苏省农业科学院 Zhongzhou honey peach essence
CN113088394B (en) * 2021-04-26 2024-02-13 江苏省农业科学院 Honey peach essence

Also Published As

Publication number Publication date
CN106967132B (en) 2019-05-21

Similar Documents

Publication Publication Date Title
CN102070695B (en) Preparation and application of ergosterol derivatives
CN105859816B (en) Method, application and the product of Sitosterolum and β daucosterols are extracted in fructus cannabis
US20040162246A1 (en) Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, cistanche tubulosa (schenk.) wight, process of making the same, and uses of the same
EP2324840B1 (en) Production of caffeoylquinic acids from plant cell cultures of echinacea angustifolia
CN111961022B (en) A kind of biflavonoid compound with neuroprotective effect and its extraction and separation method
CN102603818B (en) Preparation method and use of cerebroside compounds
CN103360452B (en) The Synthesis and applications of Muskmelon Base tetracyclic triterpene cucurbitane compound
CN102370635B (en) Application and preparation method of novel nardosinone
CN111153908B (en) Azophilic ketone alkaloid with anti-tumor activity, preparation method and application thereof
CN106967132A (en) Reactive compound and its preparation method and application in Shenzhou City&#39;s honey peach
CN102250197B (en) Preparation method and application of total steroidal saponin extracts of dwarf lilyturf roots
CN103342730B (en) Preparation method of extract of traditional Chinese medicine herb of manyflower ticklover and use of the extract in anti-aging
CN105640937A (en) Application of dehydrogenation zaluzanin C
CN114621094B (en) Compound with islet protection function and preparation method and application thereof
CN102002081A (en) 9-O-beta-D-glucosyl nandinine as well as preparation method and application thereof
CN107686501B (en) Extraction method of cucurbitane-type triterpenoids and its anti-aging medicinal use
CN103275138B (en) Sixteen carbon diacetylated no double bond lactone type sophorolipid and its application
CN106336433B (en) A kind of arabidopsis active component extract and its preparation method and application
CN103275139B (en) 16 carbon diacetyl one double bond lactone type sophorolipid and application thereof
CN103204860B (en) Amaryllidaceae Alkaloids with Neuroprotective Effects
US20230404946A1 (en) Use of (5r,7r,10r)-12,15-dioxo-alpha-selinene in the preparation of drugs
CN114456053A (en) Benzaldehyde compound produced by marine fungi, preparation method and anti-inflammatory application thereof
CN105585573A (en) Tropolone compound, pharmaceutical composition thereof as well as preparation method and applications of tropolone compound
CN104398524B (en) Mussel steroid active component extract, preparation method and applications thereof
CN103275140B (en) The two key lactone type sophorolipids of 18 one of carbon diacetyl and application thereof

Legal Events

Date Code Title Description
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20231023

Address after: No.98 Baoheng Road, Shenzhou City, Hengshui City, Hebei Province, 052800

Patentee after: Hebei Kaixiang Health Technology Co.,Ltd.

Address before: 310058 Yuhang Tang Road, Xihu District, Hangzhou, Zhejiang 866

Patentee before: ZHEJIANG University

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20240529

Address after: No. 55 Shunda North Street, Shenzhou City, Hengshui City, Hebei Province, 053899

Patentee after: Yihe (Shenzhou) Life and Health Research Institute

Country or region after: China

Address before: No.98 Baoheng Road, Shenzhou City, Hengshui City, Hebei Province, 052800

Patentee before: Hebei Kaixiang Health Technology Co.,Ltd.

Country or region before: China